CQ Medical

CQ Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CQ Medical is a private, commercial-stage medical device company focused on the radiotherapy positioning market. It offers a comprehensive portfolio of hardware and accessory solutions, such as supine breastboards, head & neck immobilization systems, thermoplastics, and couchtops, designed to improve precision, patient comfort, and workflow efficiency in radiation oncology. The company actively invests in clinical research to validate its products and has formed strategic partnerships, like the one with Radiating Hope, to expand global access to cancer care. Its business model is based on selling capital equipment and disposable/ reusable accessories to hospitals and cancer treatment centers worldwide.

Oncology

Technology Platform

Ecosystem of modular patient positioning and immobilization devices for radiotherapy, utilizing advanced low-attenuation materials and designed for compatibility with CT, MR, and treatment delivery systems.

Opportunities

The growing global cancer burden and increasing adoption of precision radiotherapy techniques (e.g., SBRT, proton therapy) drive demand for advanced immobilization solutions.
Expansion into adjacent markets like interventional radiology and veterinary medicine, along with strategic efforts to improve access in emerging economies, presents significant growth vectors.

Risk Factors

The company faces intense competition from established medical device firms in the radiotherapy space and is dependent on the capital expenditure cycles of hospitals and the success of OEM treatment system platforms.
Regulatory requirements for medical devices and evolving reimbursement landscapes pose ongoing challenges.

Competitive Landscape

CQ Medical competes in the radiotherapy positioning market against established players such as CIVCO Radiotherapy (Accuray), Orfit Industries, and Bionix Radiation Therapy. Competition is based on product innovation, clinical evidence, material science (low attenuation), system compatibility, and price. The market is niche but critical to radiation oncology workflow and precision.